Diverse responses between human pancreatic cancer cell lines to native alpha 1-antitrypsin and its C-terminal fragment.
(2003) In Anticancer research 23(3B). p.2267-2273- Abstract
- BACKGROUND: Previous studies imply that human pancreatic cancer cells have a wide heterogeneity and their exposure to various agents may give unpredictable results in clinical situations. MATERIALS AND METHODS: The cell lines LPC-3, -5 and -10, established from primary cultures of pancreatic adenocarcinoma, were exposed to 5 microM of AAT or its C-terminal peptide C-36 for 24 hours and analysed for cytokines by an enzyme-linked immunosorbent assay and for NF kappa B by the electrophoretic mobility shift assay. RESULTS: Native AAT lowers TGF-beta 1 levels and increases NF-kappa B activity in LPC-3 cells, while C-36 increases TGF-beta 1 levels and up-regulates NF-kappa B in LPC-5 cells. In LPC-10 cells AAT lowers TGF-beta 1. However, both... (More)
- BACKGROUND: Previous studies imply that human pancreatic cancer cells have a wide heterogeneity and their exposure to various agents may give unpredictable results in clinical situations. MATERIALS AND METHODS: The cell lines LPC-3, -5 and -10, established from primary cultures of pancreatic adenocarcinoma, were exposed to 5 microM of AAT or its C-terminal peptide C-36 for 24 hours and analysed for cytokines by an enzyme-linked immunosorbent assay and for NF kappa B by the electrophoretic mobility shift assay. RESULTS: Native AAT lowers TGF-beta 1 levels and increases NF-kappa B activity in LPC-3 cells, while C-36 increases TGF-beta 1 levels and up-regulates NF-kappa B in LPC-5 cells. In LPC-10 cells AAT lowers TGF-beta 1. However, both AAT and C-36 fail to cause a change in NF-kappa B expression. For LPC-10 cells treated with C-36 IL-6 and TNF-alpha levels also increase. CONCLUSION: Our findings provide evidence that human cancer cell lines originating from primary pancreatic tumors do not have a uniform response to the same stimulus which shows a great heterogenicity among pancreatic cancer cells. Serine proteinase inhibitor, AAT, dependent on its molecular form, is also found to exert diverse effects on the properties of tumour cells confirming the complexity of cell-protein interaction. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/117542
- author
- Zelvyté, Inga LU ; Ohlsson, Bodil LU ; Axelson, Jan LU and Janciauskiene, Sabina LU
- organization
- publishing date
- 2003
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Cytokines: immunology, Human, Cytokines: biosynthesis, Carcinoma, Cultured, Tumor Necrosis Factor: biosynthesis, Tumor Necrosis Factor: immunology, alpha 1-Antitrypsin: pharmacology, Pancreatic Ductal: immunology, Pancreatic Ductal: metabolism, Interleukin-6: biosynthesis, Interleukin-6: immunology, NF-kappa B: biosynthesis, Pancreatic Neoplasms: immunology, Pancreatic Neoplasms: metabolism, Peptide Fragments: pharmacology, Transforming Growth Factor beta: biosynthesis, Transforming Growth Factor beta: immunology, Tumor Cells
- in
- Anticancer research
- volume
- 23
- issue
- 3B
- pages
- 2267 - 2273
- publisher
- International Institute of Cancer Research
- external identifiers
-
- wos:000184359200009
- ISSN
- 1791-7530
- language
- English
- LU publication?
- yes
- id
- aa976b41-258b-4ed0-9c27-1f2ca94ba2b1 (old id 117542)
- alternative location
- http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=12894502&dopt=AbstractPlus
- date added to LUP
- 2016-04-01 12:00:21
- date last changed
- 2018-11-21 20:02:44
@article{aa976b41-258b-4ed0-9c27-1f2ca94ba2b1,
abstract = {{BACKGROUND: Previous studies imply that human pancreatic cancer cells have a wide heterogeneity and their exposure to various agents may give unpredictable results in clinical situations. MATERIALS AND METHODS: The cell lines LPC-3, -5 and -10, established from primary cultures of pancreatic adenocarcinoma, were exposed to 5 microM of AAT or its C-terminal peptide C-36 for 24 hours and analysed for cytokines by an enzyme-linked immunosorbent assay and for NF kappa B by the electrophoretic mobility shift assay. RESULTS: Native AAT lowers TGF-beta 1 levels and increases NF-kappa B activity in LPC-3 cells, while C-36 increases TGF-beta 1 levels and up-regulates NF-kappa B in LPC-5 cells. In LPC-10 cells AAT lowers TGF-beta 1. However, both AAT and C-36 fail to cause a change in NF-kappa B expression. For LPC-10 cells treated with C-36 IL-6 and TNF-alpha levels also increase. CONCLUSION: Our findings provide evidence that human cancer cell lines originating from primary pancreatic tumors do not have a uniform response to the same stimulus which shows a great heterogenicity among pancreatic cancer cells. Serine proteinase inhibitor, AAT, dependent on its molecular form, is also found to exert diverse effects on the properties of tumour cells confirming the complexity of cell-protein interaction.}},
author = {{Zelvyté, Inga and Ohlsson, Bodil and Axelson, Jan and Janciauskiene, Sabina}},
issn = {{1791-7530}},
keywords = {{Cytokines: immunology; Human; Cytokines: biosynthesis; Carcinoma; Cultured; Tumor Necrosis Factor: biosynthesis; Tumor Necrosis Factor: immunology; alpha 1-Antitrypsin: pharmacology; Pancreatic Ductal: immunology; Pancreatic Ductal: metabolism; Interleukin-6: biosynthesis; Interleukin-6: immunology; NF-kappa B: biosynthesis; Pancreatic Neoplasms: immunology; Pancreatic Neoplasms: metabolism; Peptide Fragments: pharmacology; Transforming Growth Factor beta: biosynthesis; Transforming Growth Factor beta: immunology; Tumor Cells}},
language = {{eng}},
number = {{3B}},
pages = {{2267--2273}},
publisher = {{International Institute of Cancer Research}},
series = {{Anticancer research}},
title = {{Diverse responses between human pancreatic cancer cell lines to native alpha 1-antitrypsin and its C-terminal fragment.}},
url = {{http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=12894502&dopt=AbstractPlus}},
volume = {{23}},
year = {{2003}},
}